Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-22

FDA Approved: NALTREXONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for naltrexone hydrochloride from Sun Pharmaceutical Industries, Inc., updating an existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone hydrochloride (Naltrexone hydrochloride)

Snippet

SUPPL AP for NALTREXONE HYDROCHLORIDE (NALTREXONE HYDROCHLORIDE)